<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_Labjournals_SurChem_September skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/Labjournals/SurChem/September</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&quot;&quot;</TITLE></P><DIV id="header"><DIV id="naviconwrapper"><DIV id="naviconbar"><DIV id="navicons"><UL><LI id="home"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="team"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="results"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="policy" style="font-size:11px"><A href="https://2015.igem.org/Team:Freiburg/Practices">Human Practice</A></LI><LI id="notebook"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL></DIV></DIV></DIV><DIV id="navtextwrapper"><DIV id="navtext"><UL id="project-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Overview">Introduction</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/System">Overview</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Design">Diagnostics today</A></LI><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/DNA_Engineering">DNA Engineering</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Cellfree_Expression">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Protein_Purification">Protein Purification</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Surface_Chemistry">Surface Chemistry</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/iRIf">Optical Detection</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Future_Directions">Outlook</A></LI><UL id="team-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Team">Members</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Attributions">Acknowledgements</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Partners">Partners</A></LI></UL><UL id="results-sub"><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results">Main Results</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Diagnostics">Diagnostics</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Own_Device">Our Device</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Immobilization">DNA Array</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Surface">Binding on Surface</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Modeling">Modeling</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Parts">BioBricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Collaborations">Collaborations</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/InterLab_Study">Interlab Study</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Achievements">Achievements</A></LI><UL id="policy-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Science_Fair">Science Fair</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Theater_Project">Theater Project</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Public_Opinion">Public Opinion</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/College">College Talk</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Ethics">Ethics</A></LI></UL><UL id="notebook-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Labjournals">Labjournals</A></LI><LI><A class="navsub1 subsubmenu" href="#">Techniques</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Classic_vs_Gibson">Gibson</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Coli_Strains">E.coli Strains</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Protocols">Protocols</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Materials">Materials</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Safety">Safety</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Wikimigration">Wiki-Tricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Glossary">Glossary</A></LI></DIV></DIV></DIV><DIV class="clearfix" id="smallnav"><UL class="clearfix"><LI id="home_small"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project_small"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="results_small"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="team_small"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="policy_small"><A href="https://2015.igem.org/Team:Freiburg/Practices">Practice</A></LI><LI id="notebook_small"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL><A href="#" id="pull">Menu</A></DIV><DIV class="content_background_wrapper"><DIV class="central_position_wrap"><DIV class="page_content"><DIV class="button_back"><A style="color:#FFF" href="https://2015.igem.org/Team:Freiburg/Labjournals#surchem_lab">&lt;&lt; Back</A></DIV><DIV class="content_box"><H1 class="sectionedit1">Labjournal Surchem September</H1><H2 class="sectionedit2">Experiment 68a:  Tetanus antigen on  PDITC slides IX</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit3">2015.09.16</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI></UL></DIV><H3 class="sectionedit4">2015.09.16</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit5"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row8"><TD class="col0"> 8 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
  * spots were incubated o/n at 4 °C
</P></DIV><H3 class="sectionedit6">2015.09.17</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Tet serum (-+): 024, 466</P><DIV class="table sectionedit7"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Serum(-)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1.5 µg/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Serum(-)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Tet serum (+-): 208, 216 </P><DIV class="table sectionedit8"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Serum(-)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1.5 µg/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Serum(+)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
GFP; Tet serum (-+): 287 </P><DIV class="table sectionedit9"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1.5 µg/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum(-)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Serum(+)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
Serum(-),anti GFP,Serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 024: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 024: binding curves</DIV></DIV></DIV><P>
]
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: binding curves</DIV></DIV></DIV><P>
Serum(+),anti GFP,Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: binding curves</DIV></DIV></DIV><P>
anti GFP,Serum(-),Serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: anti GFP, serum(-), serum(+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: binding curves</DIV></DIV></DIV></DIV><H2 class="sectionedit10">Experiment 67b:  Tetanus antigen on  PDITC slides VIII</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit11">2015.09.12</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI></UL></DIV><H3 class="sectionedit12">2015.09.13</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit13"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> - </TD><TD class="col2"> - </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1">-</TD><TD class="col2"> - </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV><P>
  * spots were incubated o/n at 4 °C
</P></DIV><H3 class="sectionedit14">2015.09.14</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Tet serum (-): 208, 254 

Tet serum (+): 500, 024
</P><DIV class="table sectionedit15"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:20</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti Human</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">StrepCy5</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
Blood Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Quotion picture, flushed with 1:20 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: binding curves</DIV></DIV></DIV><P>
]
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Quotion picture, flushed with 1:20 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: binding curves</DIV></DIV></DIV><P>
Blood serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 024: Quotion picture, flushed with 1:20 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 024: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: Quotion picture, flushed with 1:20 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: binding curves</DIV></DIV></DIV></DIV><H2 class="sectionedit16">Experiment 67a:  Tetanus antigen on  PDITC slides VII</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit17">2015.09.12</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI></UL><P>
Spotting pattern: </P><DIV class="table sectionedit18"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> - </TD><TD class="col2"> - </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1">-</TD><TD class="col2"> - </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV><P>
  * spots were incubated o/n at 4 °C
</P></DIV><H3 class="sectionedit19">2015.09.13</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Tet serum (-): 443, 466 

Tet serum (+): 423, 424
</P><DIV class="table sectionedit20"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti Human</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">StrepCy5</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
Blood Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: Quotion picture, flushed with 1:10 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: binding curves</DIV></DIV></DIV><P>
]
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: Quotion picture, flushed with 1:10 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: binding curves</DIV></DIV></DIV><P>
Blood serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423: Quotion picture, flushed with 1:10 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 424: Quotion picture, flushed with 1:10 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 424: binding curves</DIV></DIV></DIV></DIV><H2 class="sectionedit21">Experiment 66b:   PDITC slides  for iRIf</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit22">2015.09.06</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 6 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H2 class="sectionedit23">Experiment 66a:   PDITC slides  for iRIf</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit24">2015.09.06</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit25">2015.09.10</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were sandwiched with NTA and incubated at 4°C o/n</DIV></LI></UL></DIV><H3 class="sectionedit26">2015.09.10</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were blocked with APTES blocking solution for 1 h</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2x with PBS</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated with NiSO<SUB>4</SUB>-solution for 1 h and 20 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed with PBS/2x diluted PBS</DIV></LI></UL><DIV class="noteimportant">uploaded 20150906
</DIV></DIV><H2 class="sectionedit27">Experiment 65c:  Tetanus antigen PDITC slides  for iRIf VI</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit28">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 30 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit29">2015.09.05</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit30"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> - </TD><TD class="col2"> - </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1">-</TD><TD class="col2"> - </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit31">2015.09.06</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><P>
Tet serum (-): 443 

Tet serum (+): 466
</P><DIV class="table sectionedit32"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:4</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Tet serum (-): 208

Tet serum (+): 303
</P><DIV class="table sectionedit33"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1:6</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Note: the amount of flushed serum 
</P></DIV><H4>Results</H4><DIV class="level4"><P>
Blood Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Quotion picture, flushed with 1:6 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: binding curves</DIV></DIV></DIV><P>
]
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: Quotion picture, flushed with 1:4 diluted blood serum (-)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: binding curves</DIV></DIV></DIV><P>
Blood serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Quotion picture, flushed with 1:6 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: Quotion picture, flushed with 1:4 diluted blood serum (+)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: binding curves</DIV></DIV></DIV><P>
→ for the blood serum after immunization (+) the iRIf signal for tetanus binding is higher than for the blood serum before immunization (-)
</P><P>
→ there are differences to the results of experiment 59a, the overall tetanus signal is much weaker as well as the binding of the blood serum to bBSA
</P></DIV><H2 class="sectionedit34">Experiment 65b:  Tetanus antigen PDITC slides  for iRIf V</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit35">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 30 min</DIV></LI></UL></DIV><H3 class="sectionedit36">2015.09.04</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit37"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> - </TD><TD class="col2"> - </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1">-</TD><TD class="col2"> - </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit38">2015.09.05</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><P>
SIG 003 (+): 012(no serum was flushed over the slide), 315, 426

SIG 002 (+): 215
</P><DIV class="table sectionedit39"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Blood serum</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:30</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
SIG 003:
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 012: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 012: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 315: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 426: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 426: binding curves</DIV></DIV></DIV><P>
→ slide 012 was not flushed with any blood serum
→ for blood serum SIG 003 only a slight antigen/antibody binding is detectable (slide 426)
</P><P>
SIG 002:
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: binding curves</DIV></DIV></DIV><P>
→ slight antigen/antibody binding is detectable
</P><P>
→ no anti GFP/ GFP binding detected
</P><P>
→ only weak binding of the blood serum to bBSA → difference to results of experiment 59a
</P></DIV><H2 class="sectionedit40">Experiment 65a: cell free GFP on NiNTA and PDITC slides  for iRIf</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit41">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 2 PDITC slides were prepared (216,254)</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 30 min</DIV></LI><LI class="level1"><DIV class="li"> 2 Ni NTA slides from experiment 63b were also spotted (102,502)</DIV></LI></UL></DIV><H3 class="sectionedit42">2015.09.04</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern:</P><DIV class="table sectionedit43"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> cell free expression mix without DNA (KK)</TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> cell free expressed HA-GFP-His6-His6 (KK)  </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1">pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1">cell free expression mix without DNA (KK)</TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">cell free expressed His10-GFP-Spy (KK)</TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1">BSA</TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row8"><TD class="col0"> 8 </TD><TD class="col1">bBSA</TD><TD class="col2"> 200 µg/ml </TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit44">2015.09.05</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><DIV class="table sectionedit45"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
PDITC:
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: binding curves</DIV></DIV></DIV><P>
Ni-NTA:
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 102: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 102: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Quotion picture</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: binding curves</DIV></DIV></DIV><P>
→ the his tagged, cell free GFP was specificly bound by the Ni NTA surface, whereas there was no detectable amount of cell free GFP bound on the PDITC surfaces
</P><P>
→ the PDITC surface binds all proteins in the spotted cell free expression mix eaqually good, whereas the Ni-NTA surface specificly binds only the his tagged, cell free expressed GFP
</P></DIV><H2 class="sectionedit46">Experiment 64c:  Tetanus antigen PDITC slides  for iRIf IV</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit47">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit48">2015.09.03</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit49"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> BSA </TD><TD class="col2"> 5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> - </TD><TD class="col2"> - </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> mCherry</TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit50">2015.09.04</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><P>
Tet serum (-): 500(1:10 diluted serum)

Tet serum (+): 024 (1:10 diluted serum), 504 (1:30 diluted serum)
</P><DIV class="table sectionedit51"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10/1:30</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: Quotion picture, Tet serum (-), 1:10 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: binding curves</DIV></DIV></DIV><P>
Serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 024: Quotion picture, Tet serum (+), 1:10 diluted</DIV></DIV></DIV><P>
→ bad measurement, no binding curves were obtained
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 504: Quotion picture, Tet serum (+), 1:30 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 504: binding curves</DIV></DIV></DIV><P>
→ signal for 1:10 dilution of the blood serum much better → continue with 1:10 dilution
</P></DIV><H2 class="sectionedit52">Experiment 64b: Tetanus antigen PDITC slides  for iRIf III</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit53">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit54">2015.09.02</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit55"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> mCherry </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1 leftalign"> Tetanus Antigen  </TD><TD class="col2"> ~0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> BSA </TD><TD class="col2"> 10 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> BSA +bBSA</TD><TD class="col2"> 10 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1">bBSA </TD><TD class="col2"> 200 µg/ml</TD></TR></TBODY></TABLE></DIV><P>
note: bBSA on spot 5 was incubated for only a minute and then replaced with BSA   
</P></DIV><H3 class="sectionedit56">2015.09.03</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><P>
Tet serum (-): 287 (1:10 diluted serum),429 (1:30 diluted serum)

Tet serum (+): 443 (1:10 diluted serum), 423 (1:30 diluted serum)
</P><DIV class="table sectionedit57"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)/(+)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:10</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
Serum(-):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: Quotion picture, Tet serum (-), 1:10 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 429: Quotion picture, Tet serum (-), 1:30 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 429: binding curves</DIV></DIV></DIV><P>
→ higher dilution of the blood serum leads to weaker iRif signal for mCherry, BSA,BSA+bBSA and bBSA but also for the tetanus antigen
</P><P>
Serum(+):
</P><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: Quotion picture, Tet serum (+), 1:10 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: binding curves</DIV></DIV></DIV><DIV class="thumb2 tleft" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423: Quotion picture, Tet serum (+), 1:30 diluted</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:510px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423: binding curves</DIV></DIV></DIV><P>
→ higher dilution of the blood serum leads to weaker iRif signal for mCherry, BSA,BSA+bBSA and bBSA but also for the tetanus antigen
</P><P>
→ signal of the tetanus antigen spot very weak compared to experiment 59a → use fresh stock of tetanus antigen next time
</P><P>
→ unspecific binding to the BSA spot is most of the time weaker than to mCherry → from now on BSA will be used as negative contol for blood serum
</P></DIV><H2 class="sectionedit58">Experiment 64a: Salmonella antigen on PDITC slides  for iRIf II</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H3 class="sectionedit59">2015.08.31</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 3 PDITC slides were prepared</DIV></LI><LI class="level1"><DIV class="li"> Plasma activation: 40 L/h, 5 min</DIV></LI><LI class="level1"><DIV class="li"> APTES incubation: 30 min</DIV></LI><LI class="level1"><DIV class="li"> PDITC incubation: 2 h</DIV></LI><LI class="level1"><DIV class="li"> desiccator: 15 min</DIV></LI><LI class="level1"><DIV class="li"> stored at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit60">2015.09.01</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Spotting pattern: </P><DIV class="table sectionedit61"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> bBSA </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> Salmonella Antigen (15) </TD><TD class="col2"> undiluted </TD></TR></TBODY></TABLE></DIV><P>
Slides (3): 208,215,216
</P></DIV><H3 class="sectionedit62">2015.09.02</H3><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Flush protocol:
</P><DIV class="table sectionedit63"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (TBS)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer (TBS)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1,5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer (TBS)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti-Salmonella (13, desalt)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">undiluted</TD></TR><TR class="row7"><TD class="col0">Buffer (TBS)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy5</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer (TBS)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
last slide (208) changed protocol: only 1 ug/ml anti-GFP used; anti-Salmonella desalt was mixed 1:1 with anti-Salmonella lysate
</P></DIV><H4>Results</H4><DIV class="level4"><P>
Note: Slide 208 had the best signal.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>